Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV for Bronchoscopic Lung Volume Reduction (BLVR) Procedures

NCT04161235 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT04161235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04161235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV for Bronchoscopic Lung Volume Reduction (BLVR) Procedures
Lead sponsor
Pulmonx Corporation
Phase
Observational
Overall status
Completed
Start date
February 5, 2020
Completion date
December 30, 2021
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary emphysema